Zobrazeno 1 - 10
of 80
pro vyhledávání: '"F Verroust"'
Publikováno v:
Scandinavian Journal of Haematology. 28:233-237
Washed red blood cells (WRC) have been used for replacing the blood loss in haemophilia A patients with antibody to Factor VIII. Levels of VIII coagulant activity (VIII:C), VIII coagulant antigen (VIII:CAg) and VIII related antigen (VIIIR:Ag) have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0eab75a822372ec507473c6eb524d0
https://doi.org/10.1111/j.1600-0609.1982.tb00520.x
https://doi.org/10.1111/j.1600-0609.1982.tb00520.x
Autor:
L. Bendelac, A. Parquet, Y. Laurian, Edith Fressinaud, A. Derlon, M.F. Aillaud, M.A. Bertrand, B. Boneu, F. Verroust, A.M. Berthier, Jeanne-Yvonne Borg, Marie-Francoise Torchet, C. Guerois, M. Fiks-Sigaud, E. Subtil
Publikováno v:
Vox Sanguinis. 64:210-214
The levels of anti-human and anti-porcine factor VIII inhibitors, measured in 63 severe haemophilia A patients, lay in the ranges of < 0.2-2,600 and < 0.2-1,300 Bethesda units per ml (BU/ml), respectively, with a median cross-reactivity of 33%. In 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6373b038f6cc5365d9ce25a635765a
https://doi.org/10.1111/j.1423-0410.1993.tb03057.x
https://doi.org/10.1111/j.1423-0410.1993.tb03057.x
Autor:
F. Ferrer le Cœur, L. Noël, P. Maisonneuve, A. Parquet-Gernez, Anne-Marie Couroucé, M. Magniez, C. Guérois, Y. Laurian, F. Verroust
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 35:193-198
Sera from 273 French haemophiliacs who had received non viral inactivated concentrates, were tested for antibodies to HCV by first and second generation assays. Antibodies to HCV were detected in 66% of the sera by the first generation assays (anti-C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f365bffc88f18e3a27d65c0fce716268
https://doi.org/10.1016/s1140-4639(05)80122-4
https://doi.org/10.1016/s1140-4639(05)80122-4
Publikováno v:
Blood. 76:882-886
Home therapy with porcine factor VIIIC was safe and effective when administered to five hemophilic patients over periods of 8 1/2, 6, 4, 3 1/2, and 2 years. No significant transfusion reactions occurred. Before treatment with porcine factor VIIIC, al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f55a4ddc5b21fa4f47b7796019cde15d
https://doi.org/10.1182/blood.v76.5.882.882
https://doi.org/10.1182/blood.v76.5.882.882
Autor:
J. Peynet, A. Rafowicz, M. P. Archambeaud, F. Verroust, J.P. Dommergues, Y. Laurian, G. Tchernia
Publikováno v:
Médecine et Maladies Infectieuses. 20:460-464
Resume Les auteurs rapportent leur experience concernant le suivi longitudinal de 111 hemophiles dont la premiere seropositivite pour le VIH 1 est survenue avant l'âge de 18 ans. Avec un recul evolutif moyen de 66 ± 16 mois, 61 sujets restent asymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef460dfdec99b4af6b52890a2d79b0dc
https://doi.org/10.1016/s0399-077x(05)80821-2
https://doi.org/10.1016/s0399-077x(05)80821-2
Autor:
C. Guérois, B. Saint-Paul, Y. Laurian, Anne-Marie Couroucé, I. Assouvie-Gomez, L. Noël, F. Ferrer-Le Cœur, P. Maisonneuve, F. Verroust
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 33:375-377
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5bcc692179cfe297b8404f38718b91a
https://doi.org/10.1016/s1140-4639(05)80048-6
https://doi.org/10.1016/s1140-4639(05)80048-6
Publikováno v:
New England Journal of Medicine. 322:1232-1234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a2417450c4771c2bef7a2c6407c2aa0
https://doi.org/10.1056/nejm199004263221712
https://doi.org/10.1056/nejm199004263221712
Autor:
M, Fiks-Sigaud, L, Bendelac, A, Parquet, F, Verroust, M F, Torchet, A M, Berthier, E, Fressinaud, C, Guerois, M F, Aillaud, B, Boneu
Publikováno v:
Vox sanguinis. 64(4)
The levels of anti-human and anti-porcine factor VIII inhibitors, measured in 63 severe haemophilia A patients, lay in the ranges of0.2-2,600 and0.2-1,300 Bethesda units per ml (BU/ml), respectively, with a median cross-reactivity of 33%. In 4 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c54256c58e7efaceba51790adc4b9594
https://pubmed.ncbi.nlm.nih.gov/8517049
https://pubmed.ncbi.nlm.nih.gov/8517049
Autor:
P, Maisonneuve, A M, Couroucé, F, Ferrer le Coeur, C, Guérois, Y, Laurian, M, Magniez, A, Parquet-Gernez, F, Verroust, L, Noël
Publikováno v:
Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine. 35(3)
Sera from 273 French haemophiliacs who had received non viral inactivated concentrates, were tested for antibodies to HCV by first and second generation assays. Antibodies to HCV were detected in 66% of the sera by the first generation assays (anti-C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a19fae8ba701fc1eff942b9ab6200cd9
https://pubmed.ncbi.nlm.nih.gov/1384524
https://pubmed.ncbi.nlm.nih.gov/1384524
Autor:
P, Maisonneuve, Y, Laurian, C, Guerois, F, Verroust, F, Ferrer Le Coeur, A M, Couroucé, L, Noel
Publikováno v:
Nouvelle revue francaise d'hematologie. 33(3)
486 patients followed in four French hemophilia centres were tested for antibody to hepatitis C virus C100-3 recombinant protein. On samples collected in 1989, the overall incidence of anti-C 100-3 positivity was 66%. None of the 27 patients only exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ae5783c678f3a22dbde2761222a1f0e
https://pubmed.ncbi.nlm.nih.gov/1956764
https://pubmed.ncbi.nlm.nih.gov/1956764